On Younggwon, Lee Sung Young, Yoo Jung Sik, Kim Jung Wook
Division of Antimicrobial Resistance Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si 28159, Republic of Korea.
Division of Zoonotic and Vector-Borne Disease Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si 28160, Republic of Korea.
Antibiotics (Basel). 2025 Jun 3;14(6):571. doi: 10.3390/antibiotics14060571.
Linezolid resistance among species poses a growing clinical and public health concern, especially due to the dissemination of transferable resistance genes, such as . This study aimed to evaluate the prevalence of linezolid resistance and to characterize the molecular epidemiology and genetic contexts of -positive linezolid-resistant (LRE) isolates from clinical and animal sources in South Korea. A total of 2156 isolates, collected through nationwide surveillance from hospitalized patients and healthy livestock (pigs, cattle, and chickens) between 2017 and 2019, were retrospectively analyzed. Phenotypic susceptibility testing, gene screening, and whole-genome sequencing were performed to investigate genetic environments and phylogenetic relationships. The prevalence of linezolid resistance was 0.2% in clinical isolates, 3.3% in pigs, 4.3% in cattle, and 1.4% in chickens. -positive linezolid-resistant isolates were less frequent, with rates of 0.1%, 1.4%, 0.9%, and 1.0%, respectively. Multilocus sequence typing identified sequence types (STs) 330 and ST476 in from humans, with no shared STs between human and livestock isolates. The gene was located either chromosomally, frequently associated with transposon Tn6674, or on multidrug resistance plasmids. Notably, variants exhibited host-specific distribution patterns. Phylogenetic analysis demonstrated considerable genomic diversity, and Korean ST476 isolates were genetically related to international strains reported from livestock, poultry products, and wild birds, suggesting potential global dissemination. This study provides a comprehensive, nationally representative assessment of linezolid resistance in South Korea. The findings highlight the zoonotic potential and possible international dissemination of -carrying ST476 lineages, underscoring the need for integrated One Health surveillance to monitor and control the spread of transferable resistance genes.
物种对利奈唑胺的耐药性引发了越来越多的临床和公共卫生问题,尤其是由于可转移耐药基因(如……)的传播。本研究旨在评估利奈唑胺耐药性的流行情况,并对来自韩国临床和动物源的阳性利奈唑胺耐药(LRE)分离株的分子流行病学和基因背景进行特征分析。通过全国范围内的监测,收集了2017年至2019年间住院患者和健康家畜(猪、牛和鸡)的2156株分离株,并进行回顾性分析。进行了表型药敏试验、基因筛查和全基因组测序,以研究基因环境和系统发育关系。临床分离株中利奈唑胺耐药率为0.2%,猪为3.3%,牛为4.3%,鸡为1.4%。阳性利奈唑胺耐药分离株较少见,发生率分别为0.1%、1.4%、0.9%和1.0%。多位点序列分型在人类分离株中鉴定出序列类型(STs)330和ST476,人类和家畜分离株之间没有共享的STs。该基因位于染色体上,通常与转座子Tn6674相关,或位于多药耐药质粒上。值得注意的是,变体表现出宿主特异性分布模式。系统发育分析表明存在相当大的基因组多样性,韩国的ST476分离株与从家畜、家禽产品和野生鸟类中报道的国际菌株在基因上相关,表明可能存在全球传播。本研究提供了对韩国利奈唑胺耐药性的全面、具有全国代表性的评估。研究结果突出了携带ST476谱系的人畜共患病潜力和可能的国际传播,强调了需要进行综合的“同一健康”监测,以监测和控制可转移耐药基因的传播。